MannKind (MNKD) News Today $4.12 -0.10 (-2.37%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$4.15 +0.03 (+0.73%) As of 05/23/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MNKD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Two Sigma Advisers LP Boosts Stock Holdings in MannKind Co. (NASDAQ:MNKD)Two Sigma Advisers LP increased its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 16.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,092,627 shares of the biopharmaceutical company's stock after buyingMay 24 at 4:52 AM | marketbeat.comTwo Sigma Investments LP Boosts Stock Holdings in MannKind Co. (NASDAQ:MNKD)Two Sigma Investments LP raised its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 4.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,174,164 shares of the biopharmaceutical company's stock afMay 24 at 4:46 AM | marketbeat.comMan Group plc Purchases 219,891 Shares of MannKind Co. (NASDAQ:MNKD)Man Group plc boosted its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 61.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 578,310 shares of the biopharmaceutical company's stock after buying an additionMay 24 at 4:13 AM | marketbeat.comMillennium Management LLC Has $22.17 Million Stake in MannKind Co. (NASDAQ:MNKD)Millennium Management LLC raised its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 108.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,447,392 shares of the biopharmaceutical company's stoMay 23 at 4:00 AM | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Acquired by Deutsche Bank AGDeutsche Bank AG grew its stake in MannKind Co. (NASDAQ:MNKD - Free Report) by 17.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 509,738 shares of the biopharmaceutical company's stock after purchasingMay 23 at 3:34 AM | marketbeat.comBank of America Corp DE Raises Position in MannKind Co. (NASDAQ:MNKD)Bank of America Corp DE lifted its holdings in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 29.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,364,313 shares of the biopharmaceutical company's stock after puMay 22 at 3:36 AM | marketbeat.comInsider Selling: MannKind Co. (NASDAQ:MNKD) EVP Sells 2,345 Shares of StockMay 21, 2025 | insidertrades.comNomura Holdings Inc. Sells 2,792,237 Shares of MannKind Co. (NASDAQ:MNKD)Nomura Holdings Inc. lowered its holdings in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 94.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 161,959 shares of the biopharmaceutical company's stock after selliMay 21, 2025 | marketbeat.comMannKind Stockholders Approve Board and CompensationMay 19, 2025 | tipranks.comMannKind (NASDAQ:MNKD) Trading Down 3.6% After Insider SellingMay 18, 2025 | americanbankingnews.comDavid Thomson Sells 32,179 Shares of MannKind Co. (NASDAQ:MNKD) StockMay 16, 2025 | insidertrades.comMannKind Co. (NASDAQ:MNKD) Stake Lowered by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC cut its stake in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,126,727 shares of the biopharmaceutical company'sMay 16, 2025 | marketbeat.comCantor Fitzgerald Expects Stronger Earnings for MannKindMannKind Co. (NASDAQ:MNKD - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for MannKind in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst O. Brayer now anticipates that the biopharmaMay 16, 2025 | marketbeat.comBNP Paribas Financial Markets Boosts Stock Position in MannKind Co. (NASDAQ:MNKD)BNP Paribas Financial Markets lifted its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 66.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 783,474 shares of the biopharMay 16, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Purchased by Northern Trust CorpNorthern Trust Corp boosted its stake in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 8.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,777,784 shares of the biopharmaceutical company's stock after acquiring anMay 16, 2025 | marketbeat.comMannKind corp director Steven Binder sells $375,875 in stockMay 15, 2025 | investing.comMannKind EVP David Thomson sells shares worth $150,597May 15, 2025 | investing.comD. E. Shaw & Co. Inc. Has $27.45 Million Holdings in MannKind Co. (NASDAQ:MNKD)D. E. Shaw & Co. Inc. grew its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 23.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,269,063 shares of the biopharmaceMay 14, 2025 | marketbeat.comMannKind to Present at Upcoming Investor ConferencesMay 13, 2025 | globenewswire.comPromising Clinical Data and Market Potential Drive Buy Rating for MannKind’s AfrezzaMay 12, 2025 | tipranks.comGraham Capital Management L.P. Makes New Investment in MannKind Co. (NASDAQ:MNKD)Graham Capital Management L.P. acquired a new stake in shares of MannKind Co. (NASDAQ:MNKD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,590,761 shares of the biMay 12, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Sold by Tudor Investment Corp ET ALTudor Investment Corp ET AL reduced its stake in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 45.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,382 shares of the biopharmaceutical companMay 11, 2025 | marketbeat.comDimensional Fund Advisors LP Acquires 855,261 Shares of MannKind Co. (NASDAQ:MNKD)Dimensional Fund Advisors LP increased its holdings in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 40.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,958,219 shares of the biopharmaceutical company'sMay 10, 2025 | marketbeat.comMannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term GainMay 9, 2025 | insidermonkey.comSchonfeld Strategic Advisors LLC Trims Stock Position in MannKind Co. (NASDAQ:MNKD)Schonfeld Strategic Advisors LLC decreased its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 80.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 237,660 shares of the biopharmaceutical company's stock after selling 1,May 9, 2025 | marketbeat.comDecoding MannKind Corp (MNKD): A Strategic SWOT InsightMay 9, 2025 | gurufocus.comMannKind’s Promising Growth and Strategic Advancements Justify Buy RatingMay 8, 2025 | tipranks.comMannKind Corporation (MNKD) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comMannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 8, 2025 | globenewswire.comMannKind Q1 2025 Earnings PreviewMay 7, 2025 | msn.comFreestone Grove Partners LP Makes New Investment in MannKind Co. (NASDAQ:MNKD)Freestone Grove Partners LP purchased a new stake in shares of MannKind Co. (NASDAQ:MNKD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 56,332 shares of the biopharmaceutical company's stock, valued at appMay 7, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from AnalystsMannKind Co. (NASDAQ:MNKD - Get Free Report) has earned an average rating of "Buy" from the nine analysts that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the compMay 6, 2025 | marketbeat.comMannKind (MNKD) to Release Earnings on ThursdayMannKind (NASDAQ:MNKD) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-mannkind-co-stock/)May 5, 2025 | marketbeat.comManatuck Hill Partners LLC Acquires 75,000 Shares of MannKind Co. (NASDAQ:MNKD)Manatuck Hill Partners LLC increased its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 33.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 300,000 shares of the biopharmaceutical company's stock after buyMay 4, 2025 | marketbeat.comVoya Investment Management LLC Trims Position in MannKind Co. (NASDAQ:MNKD)Voya Investment Management LLC cut its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 14.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 517,460 shares of the biopharmaceutical company's stock after selling 86,155 shares during the period. Voya IMay 4, 2025 | marketbeat.comFirst Trust Advisors LP Makes New Investment in MannKind Co. (NASDAQ:MNKD)First Trust Advisors LP acquired a new stake in MannKind Co. (NASDAQ:MNKD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 777,327 shares of the biopharmaceutical company's stock, valued at approximately $4May 4, 2025 | marketbeat.comApollo Management Holdings L.P. Sells 300,000 Shares of MannKind Co. (NASDAQ:MNKD)Apollo Management Holdings L.P. lowered its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 31.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 664,113 shares of the biopharmaceuticMay 2, 2025 | marketbeat.comMannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025May 1, 2025 | globenewswire.comRaymond James Financial Inc. Takes Position in MannKind Co. (NASDAQ:MNKD)Raymond James Financial Inc. bought a new stake in shares of MannKind Co. (NASDAQ:MNKD - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 654,624 shares of the biopharmaceutical company's stApril 29, 2025 | marketbeat.comMannKind Co. (NASDAQ:MNKD) Shares Sold by Nitorum Capital L.P.Nitorum Capital L.P. trimmed its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 4.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,747,316 shares of the biopharmaceutical company's stock after selling 410,191 shareApril 28, 2025 | marketbeat.comOberweis Asset Management Inc. Has $6.23 Million Stock Holdings in MannKind Co. (NASDAQ:MNKD)Oberweis Asset Management Inc. raised its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 21.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 968,400 shares of the biopharmaceutical company's stock after acquiring an additional 169,600 sApril 27, 2025 | marketbeat.comMariner LLC Buys New Stake in MannKind Co. (NASDAQ:MNKD)Mariner LLC purchased a new position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 263,302 shares of the biopharmaceutical company's stock, valued at appApril 27, 2025 | marketbeat.comInvesco Ltd. Lowers Stock Position in MannKind Co. (NASDAQ:MNKD)Invesco Ltd. lessened its stake in MannKind Co. (NASDAQ:MNKD - Free Report) by 27.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,220,835 shares of the biopharmaceutical company'sApril 27, 2025 | marketbeat.comMarshall Wace LLP Buys 214,873 Shares of MannKind Co. (NASDAQ:MNKD)Marshall Wace LLP boosted its stake in MannKind Co. (NASDAQ:MNKD - Free Report) by 30.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 926,683 shares of the biopharmaceutical company's stock after purchasing an additionalApril 26, 2025 | marketbeat.comWalleye Capital LLC Lowers Stock Holdings in MannKind Co. (NASDAQ:MNKD)Walleye Capital LLC lowered its stake in MannKind Co. (NASDAQ:MNKD - Free Report) by 91.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 69,409 shares of the biopharmaceutical company's stock after selling 749,193 shares duApril 26, 2025 | marketbeat.comEversept Partners LP Has $5.86 Million Position in MannKind Co. (NASDAQ:MNKD)Eversept Partners LP reduced its position in shares of MannKind Co. (NASDAQ:MNKD - Free Report) by 54.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 911,025 shares of the biopharApril 24, 2025 | marketbeat.comRenaissance Technologies LLC Acquires 330,100 Shares of MannKind Co. (NASDAQ:MNKD)Renaissance Technologies LLC increased its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 50.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 981,645 shares of the biopharmaceutical company'sApril 21, 2025 | marketbeat.comWells Fargo & Company MN Sells 209,520 Shares of MannKind Co. (NASDAQ:MNKD)Wells Fargo & Company MN trimmed its holdings in MannKind Co. (NASDAQ:MNKD - Free Report) by 18.5% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 924,622 shares of the biopharmaceutical company's stock after selling 209,520 shares during theApril 21, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 190,563 Shares of MannKind Co. (NASDAQ:MNKD)Russell Investments Group Ltd. lowered its stake in MannKind Co. (NASDAQ:MNKD - Free Report) by 31.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 421,659 shares of the biopharmaceutical company's stock afteApril 20, 2025 | marketbeat.comMizuho Upgrades MannKind (NASDAQ:MNKD) to Strong-BuyMizuho raised MannKind to a "strong-buy" rating in a research report on Wednesday.April 13, 2025 | marketbeat.com Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNKD Media Mentions By Week MNKD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKD News Sentiment▼0.960.77▲Average Medical News Sentiment MNKD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKD Articles This Week▼115▲MNKD Articles Average Week Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ionis Pharmaceuticals News Alkermes News BioCryst Pharmaceuticals News Ligand Pharmaceuticals News Amicus Therapeutics News Celldex Therapeutics News Novavax News Dynavax Technologies News Innoviva News OPKO Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNKD) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MannKind Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MannKind With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
